TUESDAY, Nov. 23, 2021 (HealthDay News) — A widely available drug used to treat alcoholism has potential as a COVID-19 treatment, researchers say. The investigators found that people taking disulfiram (Antabuse) for alcoholism had a lower risk of infection with SARS-CoV-2 and were less likely to die from COVID-19 ifContinue Reading

TUESDAY, Nov. 23, 2021 (HealthDay News) — An experimental Lyme disease vaccine shows promise in animal studies and could also help protect against other tick-borne diseases, researchers say. The vaccine — which relies on the same mRNA technology used by some COVID-19 vaccines — protected guinea pigs against infection byContinue Reading

MONDAY, Nov. 22, 2021 (HealthDay News) — Hospitalized COVID-19 patients who take medications that suppress the immune system don’t have a higher risk of severe COVID-19 than those with normal immune systems, a new study finds. Early in the pandemic, it was feared that people taking immunosuppressive drugs were atContinue Reading

MONDAY, Nov. 22, 2021 (HealthDay News) — Though airborne exposure causes most cases of COVID-19, the virus lurks on objects near the beds of infected nursing home patients, according to a new study. “Coronavirus is ubiquitous and persistent in the rooms of nursing home residents with COVID-19, and highlight theContinue Reading

THURSDAY, Nov. 18, 2021 (HealthDay News) — Vaccinated health care workers with breakthrough COVID-19 infections shed less virus than those who are unvaccinated and infected, according to University of California, Los Angeles researchers. “SARS-CoV-2 viral loads are known to be a critical driver of transmission,” wrote authors led by Dr.Continue Reading

WEDNESDAY, Nov. 17, 2020 (HealthDay News) — More older folks are winding up on liver transplant waiting lists than ever before, as obesity and alcoholism supersede hepatitis C as the main cause of liver failure in the United States. The percentage of liver transplant candidates aged 65 or older roseContinue Reading